Skip to main content
UniHealth

Doctor search

Anita Agarwal, MD

Ophthalmology · San Francisco

NPI 1508940628

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
7
4 carriers
Office
1
Since medical school
40 years
Graduated 1986

Offices

1 location · West Coast Retina Medical Group Inc · 8 clinicians in this group

Looking this up.

Hospitals listed: California Pacific Medical Center- Van Ness Campus · UCSF Health Stanyan Hospital. That is not proof they admit you there this week.

Plans that list them

7 plans · 4 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Agarwal’s office at (415) 972-4600 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

7 of 7 plans

Plans whose provider directory lists this clinician
Anthem Full Dual Advantage Aligned (HMO D-SNP)Anthem Blue CrossListedOct 3, 2026
Anthem Medicare Advantage (HMO-POS)Anthem Blue CrossListedOct 3, 2026
Anthem Prime (HMO-POS)Anthem Blue Cross Partnership PlanListedOct 3, 2026
Imperial Courage Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Dynamic Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Senior Value (HMO C-SNP)Imperial Health Plan of California, Inc.ListedSep 1, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026

California Medical Board record

Licence C143103 · Current

Licensed to practise in California · since 2016 · expires 2028-06-30 · Mangalore University, Kasturba Medical College.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

State licence records

1 licence

  • Tennessee 29499Medical Doctor · since 1997 · expires 2018-06-30Specialty on the licence: Ophthalmology
    Voluntarily RetiredNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

School, training and certification

5 placements

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Ophthalmology - Ophthalmology

Education

  • Kasturba Medical CollegeMANGALORE, INDIA · 1986

Residency and fellowship

  • West Virginia Univ-Surgical Retina FellowMORGANTOWN, WV · 1998–1999
  • Vanderbilt University-Retina FellowNASHVILLE, TN · 1997–1998
  • Univ of Florida-Opthal. ResidencyGAINESVILLE, FL · 1994–1997
  • Univ of Minnesota-InternMINNEAPOLIS, MN · 1993–1994
  • Pginer-Ophthalmology-ResienceyCHANDIGARH, INDIA · 1987–1990

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend it
    Overall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
  • UCSF Health St. Mary'S HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 60% would definitely recommend it
    Overall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus

Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at California Pacific Medical Center- Van Ness Campus
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.224BetterOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.325BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.373BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.14 (0.3 to 1.97) · 2,271 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.05 (0.81 to 1.28)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths192.86 (151.51 to 234.22) · 140 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.6 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths10.3 · 60 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.5 · 143 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.8 · 356 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths14.3 · 259 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 173 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.1 · 2,316 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.31 (0.12 to 0.49) · 6,430 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.09 to 0.47) · 7,168 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.3 (1.5 to 5.09) · 2,196 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths2.47 (1.21 to 3.74) · 925 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.63 (1.37 to 3.88) · 1,954 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths10.13 (6.06 to 14.2) · 1,112 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths7.26 (4.67 to 9.85) · 1,084 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.67 (0.31 to 3.03) · 832 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.33 (0 to 0.85) · 5,406 casesNo differentJul 2022 – Jun 2024
MRSA BacteremiaInfections0.443No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.717No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.3 · 200 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits22.3 · 449 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits18.2 · 187 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits8.7 · 418 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits7.1 · 260 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits19.2 · 293 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (3.6 to 7.6) · 157 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.2 (7.7 to 13.5) · 157 casesNo differentJan 2024 – Dec 2024
Rate of readmission for CABGUnplanned return visits11 · 33 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.2 · 66 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.5 (9.4 to 16.7) · 551 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.7 to 1.3) · 219 casesNo differentJan 2024 – Dec 2024

What patients said (478 patients answered, 20% of those asked)

Patient survey stars by topic at California Pacific Medical Center- Van Ness Campus
Cleanliness4
Nurse communication3
Doctor communication3
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness3
Recommend hospital5
Share of patients giving the best answer at California Pacific Medical Center- Van Ness Campus
Room was "always" clean75%
Nurses "always" communicated well74%
Doctors "always" communicated well77%
Staff "always" explained59%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand71%
Doctors "always" listened carefully75%
Doctors "always" treated them with courtesy and respect85%
Patients who gave a rating of "9" or "10" (high)75%
Staff "always" explained new medications75%
Nurses "always" explained things so they could understand70%
Nurses "always" listened carefully71%
Nurses "always" treated them with courtesy and respect82%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital78%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms88%
See every measure and the patient survey for UCSF Health St. Mary'S Hospital

Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at UCSF Health St. Mary'S Hospital
Clostridium Difficile (C.Diff)Infections0BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.95 (0 to 1.99) · 413 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.96 (0.58 to 1.34)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths146.74 (92.54 to 200.93) · 30 casesNo differentJul 2022 – Jun 2024
Death rate for COPD patientsComplications and deaths7.4 · 35 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.8 · 51 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.6 · 220 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths9.3 · 165 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.4 · 102 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.9 · 1,363 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.24 (0.02 to 0.46) · 2,530 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.32 (0.12 to 0.53) · 2,519 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.02 (0.73 to 5.31) · 590 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.63 (0 to 3.35) · 238 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.07 (0.43 to 3.7) · 554 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths12.7 (4.19 to 21.21) · 259 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.67 (1.51 to 9.83) · 203 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.7 (0.19 to 3.2) · 168 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.21 (0 to 0.99) · 2,258 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.2 · 158 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.6 · 61 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits21.1 · 291 casesNoneJul 2023 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-3.4 · 251 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits5.5 · 189 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.1 · 213 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.7 (3.7 to 8.5) · 30 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12 (8.3 to 17.1) · 30 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits4.5 · 176 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.3 · 61 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.1 (9.6 to 17.8) · 192 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.7 to 1.5) · 113 casesNo differentJan 2024 – Dec 2024

What patients said (587 patients answered, 20% of those asked)

Patient survey stars by topic at UCSF Health St. Mary'S Hospital
Cleanliness3
Nurse communication2
Doctor communication2
Communication about medicines2
Discharge information4
Overall hospital rating2
Quietness1
Recommend hospital2
Share of patients giving the best answer at UCSF Health St. Mary'S Hospital
Room was "always" clean66%
Nurses "always" communicated well73%
Doctors "always" communicated well76%
Staff "always" explained60%
Yes, staff "did" give patients this information87%
Yes, staff "did" give patients information about help after discharge86%
Doctors "always" explained things so they could understand71%
Doctors "always" listened carefully76%
Doctors "always" treated them with courtesy and respect82%
Patients who gave a rating of "9" or "10" (high)58%
Staff "always" explained new medications73%
Nurses "always" explained things so they could understand70%
Nurses "always" listened carefully72%
Nurses "always" treated them with courtesy and respect78%
"Always" quiet at night41%
"YES", patients would definitely recommend the hospital60%
Staff "always" explained possible side effects48%
Yes, staff "did" give patients information about possible symptoms88%

Original Medicare doctor bills

$2,443,414

Medicare paid this office $2,443,414 for 973 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Injection, aflibercept, 1 mg225$1,412,116None
Injection, faricimab-svoa, 0.1 mg72$458,357None
Injection of drug into eye312$159,718$123
Established patient complete exam of visual system824$131,350$119
Imaging of retina928$57,619$40
See all 13 services
Every Original Medicare service billed
Injection, aflibercept, 1 mg225$1,412,116None
Injection, faricimab-svoa, 0.1 mg72$458,357None
Injection of drug into eye312$159,718$123
Established patient complete exam of visual system824$131,350$119
Imaging of retina928$57,619$40
Injection, ranibizumab, 0.1 mg23$47,671None
Extended exam of the back part of the eye with retinal drawing743$23,747$23
New patient complete exam of visual system147$21,324$145
Compounded drug, not otherwise classified41$9,944None
Photography of the retina218$8,363$36
Established patient problem focused exam of visual system55$6,463$94
Exam of retinal blood vessels using a special camera after injection of a dye12$2,230$186
Removal of eye fluid13$2,124$125

Procedures Medicare counted

Procedure volume Medicare published
Cataract surgery1-10None

Procedures year by year

Procedures billed to Original Medicare by year
Procedure201920202021202220232024
Injection of drug into eye1,3981,4181,2391,4881,3711,300
Removal of eye fluid14––––17
Destruction of growth of retina using a laser17–––––
Injection of drug or substance into membrane covering eyeball–––14––

Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.

Who their Medicare patients are

973 Original Medicare patients in 2024. Average age 79 · Under 65 2% · 85 and older 26% · Women 59% · Also on Medicaid 17% · Health risk score 1.27. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.

Conditions among them: High blood pressure 71% · Diabetes 27% · Chronic kidney disease 23% · Coronary heart disease 22% · Atrial fibrillation 19% · Depression 16% · Cancer 15% · Heart failure 13% · COPD 8% · Stroke 8% · Dementia 6%.

The office billed $14,969,185, Medicare allowed $3,112,636 and paid $2,443,414; for 25,214 services of 43 kinds; $1,987,543 of it was for drugs given in the office and $455,871 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
202497325,214791.27$14,969,185$2,443,414
20231,01516,717791.18$13,119,275$2,251,641
20221,12210,369791.23$11,264,255$2,034,361
20219518,657781.18$7,729,985$1,460,313
20201,0057,852791.33$7,451,561$1,371,142
20199847,953781.34$5,733,269$1,391,923
20181,0348,601791.40$5,227,729$1,555,035
20175864,775781.31$3,008,761$935,632
20167532,531751.45$1,495,197$363,716
20157642,493721.45$1,359,805$273,482
20147982,544711.43$1,174,002$208,332
20138442,637711.46$1,291,636$245,710

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 15 services

Original Medicare services billed in 2023
Injection, aflibercept, 1 mg214$1,464,607None
Injection, faricimab-svoa, 0.1 mg25$215,300None
Injection of drug into eye313$160,340$117
Established patient complete exam of visual system685$99,761$116
Injection, ranibizumab, 0.1 mg27$62,503None
Imaging of retina914$55,064$37
Compounded drug, not otherwise classified109$29,701None
Return visit (30+ min)238$23,499$93
Extended exam of the back part of the eye with retinal drawing743$22,977$22
New patient complete exam of visual system135$18,043$134
Photography of the retina254$9,572$34
New patient visit (45+ min)64$7,132$111
Established patient problem focused exam of visual system64$6,183$78
Exam of retinal blood vessels using a special camera after injection of a dye13$1,902$146
Injection, bevacizumab, 10 mg13$981None

2022: 15 services

Original Medicare services billed in 2022
Injection, aflibercept, 1 mg199$1,262,066None
Injection of drug into eye417$172,911$116
Injection, ranibizumab, 0.1 mg38$153,922None
Established patient complete exam of visual system735$108,522$109
Imaging of retina932$54,512$37
Compounded drug, not otherwise classified196$54,045None
New patient complete exam of visual system230$30,945$135
Extended exam of the back part of the eye with retinal drawing537$15,551$22
Established patient problem focused exam of visual system126$13,210$78
Photography of the retina248$9,276$33
Return visit (30+ min)50$6,318$121
Exam of retinal blood vessels using a special camera after injection of a dye40$5,146$129
Extended exam of the back part of the eye with optic nerve drawing279$3,461$11
Injection of drug or substance into membrane covering eyeball11$687$49
Injection, triamcinolone acetonide, not otherwise specified, 10 mg11$50None

2021: 13 services

Original Medicare services billed in 2021
Injection, aflibercept, 1 mg100$829,031None
Injection of drug into eye284$145,429$117
Injection, ranibizumab, 0.1 mg27$132,057None
Established patient complete exam of visual system762$116,829$110
Compounded drug, not otherwise classified171$62,115None
Imaging of retina732$44,157$38
New patient complete exam of visual system190$24,883$131
Extended exam of the back part of the eye with optic nerve drawing604$12,097$15
Photography of the retina233$9,737$37
Established patient problem focused exam of visual system86$8,417$79
Extended exam of the back part of the eye with retinal drawing204$4,768$20
Exam of retinal blood vessels using a special camera after injection of a dye36$4,547$123
2d ultrasound scan of eye tissue and structures18$967$48

2020: 12 services

Original Medicare services billed in 2020
Injection, aflibercept, 1 mg135$784,569None
Injection of drug into eye427$142,999$101
Injection, ranibizumab, 0.1 mg38$119,703None
Established patient complete exam of visual system664$87,079$108
Compounded drug, not otherwise classified269$80,016None
Imaging of retina782$46,791$37
New patient complete exam of visual system164$21,960$134
Established patient problem focused exam of visual system123$14,709$76
Photography of the retina187$8,693$42
Extended exam of the back part of the eye with retinal drawing175$4,316$23
Exam of retinal blood vessels using a special camera after injection of a dye36$3,790$105
Short return visit22$1,038$43

2019: 13 services

Original Medicare services billed in 2019
Injection, aflibercept, 1 mg100$681,413None
Injection, ranibizumab, 0.1 mg70$209,375None
Injection of drug into eye321$139,656$100
Established patient complete exam of visual system721$100,872$108
Compounded drug, not otherwise classified240$69,462None
Imaging of retina795$51,702$37
New patient complete exam of visual system208$27,787$134
Established patient problem focused exam of visual system214$24,030$78
Destruction of growth of retina using a laser12$8,523$501
Photography of the retina156$7,475$46
Examination of eye by ophthalmoscope with retinal drawing106$4,432$27
Exam of retinal blood vessels using a special camera after injection of a dye41$3,783$92
Removal of eye fluid14$1,334$95

2018: 14 services

Original Medicare services billed in 2018
Injection, aflibercept, 1 mg138$862,784None
Injection, ranibizumab, 0.1 mg51$219,641None
Injection of drug into eye421$143,543$93
Established patient complete exam of visual system672$83,109$98
Compounded drug, not otherwise classified267$65,725None
Imaging of retina824$48,521$34
Established patient problem focused exam of visual system308$34,874$71
New patient complete exam of visual system178$21,354$120
Removal of membrane of retina11$12,353$1,029
Photography of the retina219$11,960$51
Destruction of leaking blood vessels of retina using laser14$6,751$307
Destruction of growth of retina using a laser12$5,984$499
Exam of retinal blood vessels using a special camera after injection of a dye51$4,185$82
Removal of eye fluid16$2,137$107

2017: 11 services

Original Medicare services billed in 2017
Injection, aflibercept, 1 mg84$501,054None
Injection, ranibizumab, 0.1 mg25$157,294None
Injection of drug into eye234$81,450$98
New patient complete exam of visual system279$35,739$128
Established patient problem focused exam of visual system213$30,191$78
Compounded drug, not otherwise classified126$29,398None
Imaging of retina387$24,248$38
Established patient complete exam of visual system154$18,185$107
Photography of the retina180$12,826$65
Exam of retinal blood vessels using a special camera after injection of a dye42$3,270$76
Injection, bevacizumab, 10 mg12$862None

2016: 17 services

Original Medicare services billed in 2016
Injection, aflibercept, 1 mg46$179,497None
Injection of drug into eye134$25,224$85
Established patient complete exam of visual system178$16,116$85
Established patient complete exam of visual system321$16,070$48
Injection of drug into eye73$15,737$72
New patient complete exam of visual system55$7,437$135
Removal of eye fluid (vitreous) between lens and retina13$7,299$561
Imaging of retina181$7,164$34
Injection, bevacizumab, 10 mg45$7,090None
Established patient problem focused exam of visual system97$6,853$62
Established patient problem focused exam of visual system97$4,624$32
Exam of retinal blood vessels using a special camera after injection of a dye22$4,247$104
Photography of the retina50$3,567$71
Imaging of retina125$3,345$19
Compounded drug, not otherwise classified36$2,948None
New patient complete exam of visual system31$1,876$61
Photography of the retina55$807$14

2015: 19 services

Original Medicare services billed in 2015
Injection, aflibercept, 1 mg16$94,873None
Established patient complete exam of visual system435$24,066$51
Injection of drug into eye75$22,054$74
Injection of drug into eye53$15,844$76
Established patient complete exam of visual system165$15,071$82
Removal of eye fluid (vitreous) between lens and retina14$7,139$476
Established patient problem focused exam of visual system122$7,106$34
Injection, bevacizumab, 10 mg41$6,192None
Established patient problem focused exam of visual system60$4,706$52
Imaging of retina154$4,360$19
Imaging of retina81$3,830$31
New patient complete exam of visual system45$3,020$67
Removal of recurring cataract in lens capsule using a laser11$2,410$219
Photography of the retina89$1,591$17
Photography of the retina29$1,477$51
Unclassified biologics19$1,448None
New patient complete exam of visual system16$1,366$85
2d ultrasound scan of eye tissue and structures12$678$38
Exam of retinal blood vessels using a special camera after injection of a dye16$501$31

2014: 17 services

Original Medicare services billed in 2014
Established patient complete exam of visual system502$30,704$52
Injection of drug into eye81$22,639$68
Established patient complete exam of visual system180$18,392$84
Injection of drug into eye50$11,918$70
Established patient problem focused exam of visual system116$7,266$35
Injection, bevacizumab, 10 mg40$5,949None
Destruction of growth of retina using a laser11$5,844$390
Established patient problem focused exam of visual system52$5,058$54
Imaging of retina151$4,711$21
New patient complete exam of visual system58$4,054$70
Imaging of retina62$3,183$32
Photography of the retina102$1,668$16
Photography of the retina38$1,645$41
Unclassified biologics22$1,575None
Exam of retinal blood vessels using a special camera after injection of a dye13$1,388$66
Exam of retinal blood vessels using a special camera after injection of a dye26$995$33
2d ultrasound scan of eye tissue and structures12$413$34

2013: 18 services

Original Medicare services billed in 2013
Injection, aflibercept, 1 mg19$37,078None
Established patient complete exam of visual system511$30,280$51
Injection of drug into eye81$21,566$64
Established patient complete exam of visual system155$15,645$86
Injection of drug into eye46$11,358$71
Established patient problem focused exam of visual system126$8,419$36
New patient complete exam of visual system95$6,527$69
Injection, bevacizumab, 10 mg38$5,606None
Established patient problem focused exam of visual system61$5,303$56
Imaging of retina134$4,127$19
Removal of recurring cataract in lens capsule using a laser15$3,888$216
Photography of the retina148$2,516$16
Imaging of retina57$2,406$30
Exam of retinal blood vessels using a special camera after injection of a dye30$982$31
Exam of retinal blood vessels using a special camera after injection of a dye20$861$43
Photography of the retina41$774$19
2d ultrasound scan of eye tissue and structures14$643$40
Exam of visual field with extended testing16$283$18

Medicaid work

$180,969 in 2024

Medicaid paid $180,969 for 908 billed services this clinician did in 2024, up to 34 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Aflibercept injection116$102,341
Intravitreal injection of a pharmacologic agent (separate procedure)279$61,360
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST177$8,858
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina223$6,283
Ophthalmoscopy, extended; with retinal drawing and scleral depression of peripheral retinal disease (eg, for retinal tear, retinal detachment, retinal tumor) with interpretation and report, unilateral or bilateral113$2,127
Medicaid work by year
2024908534$180,969
20231,318948$370,574
20221,4701047$182,747
2021838731$50,100
2020759531$47,255
2019501427$35,766
2018204319$19,439
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Aflibercept injection157$206,793
Intravitreal injection of a pharmacologic agent (separate procedure)479$138,950
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina289$9,732
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST142$8,433
Ophthalmoscopy, extended; with retinal drawing and scleral depression of peripheral retinal disease (eg, for retinal tear, retinal detachment, retinal tumor) with interpretation and report, unilateral or bilateral174$4,207
Injection, bevacizumab, 10 mg32$1,148
Return visit (30+ min)14$705
FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT13$430
Compounded drug, not otherwise classified18$178

2022

Largest Medicaid services in 2022
Aflibercept injection144$91,646
Intravitreal injection of a pharmacologic agent (separate procedure)447$76,723
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina310$6,442
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient79$2,350
Injection, bevacizumab, 10 mg58$2,021
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST100$1,738
Ophthalmoscopy, extended; with retinal drawing and scleral depression of peripheral retinal disease (eg, for retinal tear, retinal detachment, retinal tumor) with interpretation and report, unilateral or bilateral109$1,322
Bilateral extended ophthalmoscopy with drawing of optic nerve, with interpretation and report50$407
Compounded drug, not otherwise classified22$56
Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease151$42

2021

Largest Medicaid services in 2021
Intravitreal injection of a pharmacologic agent (separate procedure)316$44,541
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina181$3,539
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST62$700
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient13$602
Bilateral extended ophthalmoscopy with drawing of optic nerve, with interpretation and report89$510
Compounded drug, not otherwise classified62$169
Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease115$41

2020

Largest Medicaid services in 2020
Intravitreal injection of a pharmacologic agent (separate procedure)328$38,758
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina220$5,060
Compounded drug, not otherwise classified169$2,140
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient26$1,002
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST16$295

2019

Largest Medicaid services in 2019
Intravitreal injection of a pharmacologic agent (separate procedure)235$30,931
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina189$4,057
Compounded drug, not otherwise classified53$448
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST24$331

2018

Largest Medicaid services in 2018
Intravitreal injection of a pharmacologic agent (separate procedure)151$18,783
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina35$519
Compounded drug, not otherwise classified18$137

Drugs they prescribed that Part D paid

$25,919

Pharmacies billed $25,919 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 235) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.

127 generic and 108 brand-name prescriptions · $25,919 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Prednisolone Acetate77$4,943$64
Dorzolamide24$417$17
Polymyxin B Sul-Trimethoprim34$254$7

Year by year

Part D prescribing by year
2024235890% (0)46%$25,919
20232661010% (0)44%$27,158
2022188810% (0)51%$9,481
2021191730% (0)49%$12,103
202022457NoneNone$16,892
201922767NoneNone$12,753
201818351NoneNone$14,973
201714754None50%$14,012
201624670None47%$24,427
20156831104% (25)None$37,337
20141,4391835% (76)None$70,163
20131,2401704% (46)22%$91,828

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 7 drugs

Part D drugs prescribed in 2023
Prednisolone Acetate85$6,019$71
Methotrexate13$810$62
Dorzolamide30$789$26
Timolol Maleate12$718$60
Ketorolac Tromethamine18$709$39
Moxifloxacin18$564$31
Polymyxin B Sul-Trimethoprim26$249$10

2022: 5 drugs

Part D drugs prescribed in 2022
Prednisolone Acetate83$6,249$75
Ketorolac Tromethamine13$335$26
Moxifloxacin11$276$25
Prednisone14$240$17
Polymyxin B Sul-Trimethoprim28$220$8

2021: 4 drugs

Part D drugs prescribed in 2021
Prednisolone Acetate77$5,909$77
Ketorolac Tromethamine14$360$26
Polymyxin B Sul-Trimethoprim37$335$9
Dorzolamide14$264$19

2020: 5 drugs

Part D drugs prescribed in 2020
Methazolamide16$6,250$391
Prednisolone Acetate64$4,759$74
Ketorolac Tromethamine17$531$31
Polymyxin B Sul-Trimethoprim23$210$9
Furosemide13$68$5

2019: 3 drugs

Part D drugs prescribed in 2019
Prednisolone Acetate51$4,712$92
Ketorolac Tromethamine18$461$26
Polymyxin B Sul-Trimethoprim29$284$10

2018: 4 drugs

Part D drugs prescribed in 2018
Prednisolone Acetate53$3,701$70
Dorzolamide13$238$18
Timolol Maleate14$133$10
Polymyxin B Sul-Trimethoprim17$132$8

2017: 2 drugs

Part D drugs prescribed in 2017
Prednisolone Acetate50$4,164$83
Polymyxin B Sul-Trimethoprim23$183$8

2016: 4 drugs

Part D drugs prescribed in 2016
Prednisolone Acetate40$3,104$78
Methotrexate24$2,487$104
Alphagan P11$2,432$221
Prednisone11$103$9

2015: 23 drugs

Part D drugs prescribed in 2015
Prednisolone Acetate47$3,290$70
Methotrexate19$2,781$146
Donepezil12$712$59
Brimonidine15$706$47
Gabapentin19$562$30
Buspirone13$545$42
Metoprolol15$412$27
Atorvastatin17$401$24
Pravastatin15$354$24
Potassium Chloride14$211$15
Omeprazole18$175$10
Metformin12$172$14
Levothyroxine16$164$10
Timolol Maleate13$148$11
Prednisone14$123$9
Warfarin14$106$8
Metoprolol11$105$10
Simvastatin14$94$7
Amlodipine Besylate17$90$5
Furosemide12$86$7
Enalapril Maleate15$78$5
Ranitidine16$64$4
Hydrochlorothiazide14$46$3

2014: 46 drugs

Part D drugs prescribed in 2014
Prednisolone Acetate58$4,129$71
Lyrica11$3,799$345
Methotrexate21$3,778$180
Acetazolamide12$2,869$239
Valacyclovir14$2,351$168
Fenofibrate16$1,446$90
Metoprolol36$1,260$35
Brimonidine14$1,095$78
Gabapentin42$1,086$26
Mycophenolate Mofetil11$1,085$99
Pravastatin45$1,064$24
Atorvastatin24$794$33
Lansoprazole11$620$56
Losartan19$608$32
Hydrocodone-Acetaminophen24$559$23
Valsartan-Hydrochlorothiazide11$515$47
Simvastatin62$476$8
Timolol Maleate17$449$26
Donepezil16$446$28
Dorzolamide11$406$37
Clopidogrel16$399$25
Omeprazole43$389$9
Potassium Chloride17$344$20
Klor-Con M2013$339$26
Levothyroxine14$282$20
Prednisone29$276$10
Enalapril Maleate28$238$9
Lisinopril31$238$8
Warfarin24$229$10
Metoprolol26$213$8
Clonazepam23$206$9
Paroxetine17$202$12
Ranitidine27$200$7
Amlodipine Besylate23$200$9
Metformin23$189$8
Sertraline21$155$7
Lisinopril-Hydrochlorothiazide19$132$7
Acetaminophen-Codeine20$128$6
Tramadol25$123$5
Hydrochlorothiazide22$119$5
Furosemide27$115$4
Allopurinol16$102$6
Terazosin12$86$7
Amitriptyline18$83$5
Trazodone21$71$3
Dicyclomine11$44$4

2013: 34 drugs

Part D drugs prescribed in 2013
Methotrexate37$3,897$105
Lantus15$3,231$215
Detrol La13$2,660$205
Atorvastatin47$1,709$36
Prednisolone Acetate58$1,296$22
Fenofibrate18$1,010$56
Metoprolol31$990$32
Potassium Chloride20$655$33
Dorzolamide-Timolol14$532$38
Omeprazole25$527$21
Losartan20$490$24
Pravastatin27$377$14
Simvastatin42$353$8
Lisinopril36$347$10
Levothyroxine15$346$23
Carvedilol30$341$11
Gabapentin23$307$13
Donepezil11$299$27
Warfarin21$261$12
Lisinopril-Hydrochlorothiazide30$259$9
Amlodipine Besylate39$254$7
Hydrocodone-Acetaminophen14$239$17
Tamsulosin11$230$21
Prednisone20$226$11
Ranitidine18$212$12
Furosemide23$212$9
Allopurinol18$208$12
Sertraline25$193$8
Tramadol20$171$9
Hydrocortisone11$154$14
Hydrochlorothiazide19$150$8
Metoprolol21$135$6
Terazosin14$100$7
Trazodone12$67$6

Money from drug and device companies

$75 in 2023

Industry payments by year
202322None$75
202213None$69
202122None$47
202011None$25
201922None$50

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Bausch & Lomb AmericasEnvista Mx60 Iol$47
1 payment
  • Meals for Envista Mx60 Iol · 2023-11-10 · $47
Regeneron Healthcare SolutionsEylea Hd$27
1 payment
  • Meals for Eylea Hd · 2023-09-22 · $27
See all 2 published payments
Every published payment
Bausch & Lomb AmericasMeals · 2023-11-10Envista Mx60 Iol$47
Regeneron Healthcare SolutionsMeals · 2023-09-22Eylea Hd$27
See earlier years (2022, 2021, 2020, 2019)

2022: $69

Payments by company in 2022
EyePoint Pharmaceuticals USDexycu$69
3 payments
  • Meals for Yutiq · 2022-08-19 · $24
  • Meals for Dexycu · 2022-05-11 · $24
  • Meals for Dexycu · 2022-01-31 · $22

2021: $47

Payments by company in 2021
Genentech USALucentis$23
1 payment
  • Meals for Lucentis · 2021-02-04 · $23
EyePoint Pharmaceuticals USDexycu$23
1 payment
  • Meals for Dexycu · 2021-11-22 · $23

2020: $25

Payments by company in 2020
Genentech USALucentis$25
1 payment
  • Meals for Lucentis · 2020-09-21 · $25

2019: $50

Payments by company in 2019
Novartis PharmaceuticalsNone$26
1 payment
  • Meals · 2019-03-11 · $26
Genentech USALucentis$25
1 payment
  • Meals for Lucentis · 2019-07-24 · $25

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
70.0 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1508940628
Licence
CA C143101, CA C143103, TN MD29499California C143103: Current · expires 2028-06-30Tennessee 29499: Voluntarily Retired
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207WX0107X (207WX0107X); Federal specialty code 207W00000X (207W00000X)
Mailing address
1445 Bush St, San Francisco, CA, 94109
NPI first listed
2006-10-25
NPI last updated
2020-08-21
NPI record certified
2020-08-21

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 100 Tamal Plz Ste 120, Corte Madera, CA, 94925 · 400 30th St Ste 402, Oakland, CA, 94609 · 101 S San Mateo Dr Ste 306, San Mateo, CA, 94401 · 1981 N Broadway Ste 265, Walnut Creek, CA, 94596

This office lists an electronic records connection.